Elixinol Wellness Ltd (ASX: EXL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Elixinol Wellness Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $6.24 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 1.32 billion
Earnings per share -0.008
Dividend per share N/A
Year To Date Return -46.43%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Elixinol Wellness Ltd (ASX: EXL)
    Latest News

    little green pharma share price represented by cannabis leaf character jumping cheerfully
    Share Market News

    ASX stock of the day: Elixinol Global (ASX:EXL) shares blaze new highs

    Elixinol Global Ltd (ASX: EXL) shares are blazing higher today, up more than 55%. Here's why this ASX cannabis company…

    Read more »

    Falling asx share price represented by man in chinos falling suspended in mid-air
    Share Market News

    Here's why ASX cannabis shares are falling today

    Here's why Cann Group Ltd (ASX: CAN) and other ASX cannabis shares are giving investors a headache today. It's got…

    Read more »

    range of hemp oil and skin products representing elixinol share price
    Share Market News

    Elixinol share price edges higher on half year earnings release

    The Elixinol share price has edged 3% higher today after the company released its half year financial results. We take…

    Read more »

    toy forklift lifting blocks stating IPO
    How to invest

    Should you ever buy into an ASX IPO?

    Here's why I think all ASX investors should be very careful about investing in an Initial Public Offering (IPO) on…

    Read more »

    Share Fallers

    Why Elixinol Global, National Storage, Qantas, & Vicinity shares are dropping lower

    National Storage REIT (ASX:NSR) and Qantas Airways Limited (ASX:QAN) shares are two of four dropping notably lower today...

    Read more »

    a woman
    Share Gainers

    Why this ASX cannabis share zoomed 9% higher today

    The Elixinol Global Ltd (ASX:EXL) share price jumped 9% higher on Thursday despite posting a $83.5 million full year loss...

    Read more »

    a woman
    Share Market News

    Cannabis share Elixinol Global announces asset sales

    The Elixinol Global Ltd (ASX:EXL) share price will be on watch on Monday after the release of an announcement this…

    Read more »

    a woman
    Share Gainers

    Why these 3 ASX cannabis shares are flying high in 2020

    These 3 ASX cannabis shares are rebounding from a weak 2019 by doubling in value. Is 2020 shaping up as…

    Read more »

    a woman
    Share Fallers

    Why cannabis company Elixinol Global is down 25% in just two days

    The Elixinol Global Ltd (ASX:EXL) share price is crashing lower again this week. Here's why its shares have been sold…

    Read more »

    a woman
    52-Week Lows

    Bank of Queensland and these ASX shares just sank to multi-year lows

    Bank of Queensland Limited (ASX:BOQ) and these ASX shares have just fallen to multi-year lows. Here's why they are sinking…

    Read more »

    a woman
    Share Fallers

    Why a2 Milk, Elixinol Global, Estia Health, & McMillan Shakespeare are dropping lower

    The A2 Milk Company Ltd (ASX:A2M) share price and the Elixinol Global Ltd (ASX:EXL) share price are two of four…

    Read more »

    a woman
    Record Lows

    Why the Elixinol Global share price crashed to a record low today

    The Elixinol Global Ltd (ASX: EXL) share price is among the biggest losers on the market today after the stock…

    Read more »

    EXL ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Elixinol Wellness Ltd

    Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the three operating segments of the Americas, Australia, Rest of the World regions of which key revenue is derived from the Australia segment. The Australia segment includes the results from operations of Elixinol Wellness (Byron Bay) Pty Ltd and The Sustainable Nutrition Group Pty Ltd and its subsidiaries.

    EXL Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    01 Nov 2024 $0.00 $0.00 0.00% 570,128 $0.00 $0.00 $0.00
    31 Oct 2024 $0.00 $0.00 0.00% 30,551 $0.00 $0.00 $0.00
    30 Oct 2024 $0.00 $0.00 0.00% 4,878,868 $0.00 $0.00 $0.00
    28 Oct 2024 $0.00 $0.00 0.00% 296,053 $0.00 $0.00 $0.00
    25 Oct 2024 $0.00 $0.00 0.00% 485 $0.00 $0.00 $0.00
    24 Oct 2024 $0.00 $0.00 0.00% 2,507,927 $0.00 $0.01 $0.00
    23 Oct 2024 $0.00 $0.00 0.00% 1,345,491 $0.00 $0.00 $0.00
    22 Oct 2024 $0.00 $0.00 0.00% 3,438,608 $0.00 $0.00 $0.00
    21 Oct 2024 $0.00 $0.00 0.00% 3,182,919 $0.00 $0.00 $0.00
    18 Oct 2024 $0.00 $0.00 0.00% 1,952,590 $0.00 $0.00 $0.00
    17 Oct 2024 $0.00 $0.00 0.00% 6,529,765 $0.00 $0.00 $0.00
    16 Oct 2024 $0.00 $0.00 0.00% 504,907 $0.00 $0.00 $0.00
    15 Oct 2024 $0.00 $0.00 0.00% 263,271 $0.00 $0.00 $0.00
    14 Oct 2024 $0.00 $0.00 0.00% 2,021,727 $0.00 $0.00 $0.00
    11 Oct 2024 $0.00 $0.00 0.00% 9,313,818 $0.00 $0.00 $0.00
    09 Oct 2024 $0.01 $0.00 0.00% 4,947,966 $0.00 $0.01 $0.00
    08 Oct 2024 $0.01 $0.00 0.00% 1,425,317 $0.00 $0.01 $0.00
    07 Oct 2024 $0.00 $0.00 0.00% 6,821 $0.00 $0.00 $0.00

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    31 May 2024 David (Dave) Fenlon Issued 3,752,345 $19,999
    Director remuneration. 4,218,098 rIGHTS
    08 Apr 2024 Natalie Butler Exercise 874,000 $5,244
    Conversion of securities. 874,000 performance rights
    08 Apr 2024 Natalie Butler Issued 874,000 $5,244
    Conversion of securities.
    28 Mar 2024 Ron Dufficy Expiry 3,171,994 $15,859
    As advised by the company. Lapsed
    28 Mar 2024 David (Dave) Fenlon Expiry 1,250,000 $6,250
    As advised by the company. 465,753 Rights, lapsed
    06 Feb 2024 Ron Dufficy Expiry 548,077 $5,480
    As advised by the company. Lapsing of Performance Share rights,31,71,994 Rights
    23 Nov 2023 David (Dave) Fenlon Issued 625,000 $8,750
    Conversion of securities.
    23 Nov 2023 David (Dave) Fenlon Issued 625,000 $8,750
    Issue of options.
    23 Nov 2023 David (Dave) Fenlon Exercise 625,000 $8,750
    Conversion of securities. 17,15,753 Rights
    23 Nov 2023 Ron Dufficy Issued 902,778 $12,638
    Conversion of securities.
    23 Nov 2023 Ron Dufficy Exercise 902,778 $12,638
    Conversion of securities. 37,20,071 Rights
    23 Nov 2023 Ron Dufficy Buy 902,778 $12,638
    Issue of options.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David (Dave) Fenlon Non-Executive DirectorNon-Executive Chairman Mar 2022
    Mr David has worked with retail brands both in Australia and offshore, with a focus on strategic planning and business transformation including in key positions with Tesco throughout Europe and Safeway in the UK. David was a member of the Board of Directors for the Special Olympics from May 2017 until June 2019. Fenlon has over 30 years of experience in the FMCG and consumer sectors. He is member of Risk Committee.
    Ms Pauline Therese Gately Non-Executive Director Aug 2023
    Ms Gately is a director who brings a commercial focus to strategy with demonstrated achievement in funding, business development, and strategic transformation having led companies through IPO, business recalibration and mergers and acquisitions. Her Board contributions are also underpinned by senior roles in international investment banking across the Asia Pacific region. She is chair of Risk Committee.
    Ms Natalie Butler Non-Executive Director Mar 2024
    --
    Ms Melanie Jaye Leydin Company Secretary Jul 2024
    -
    Melanie Jaye Leydin Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Cg Nominees (Australia) Pty Ltd 31,074,072 4.91%
    UBS Nominees Pty Ltd 20,945,417 3.31%
    Hsbc Custody Nominees (Australia) Limited 18,698,448 2.95%
    Citicorp Nominees Pty Limited 18,181,816 2.87%
    Rosedale Super Pty Ltd (Rosedale Super Fund A/C) 16,871,048 2.67%
    Raw With Life Pty Ltd (Benhaim Trading A/C) 16,692,881 2.64%
    James Robert Hood Pty Ltd (Bluestone A/C) 11,387,115 1.80%
    Mr Stuart Reseck & Mrs Nicole Deanne Reseck (Reseck Super Fund A/C) 11,000,000 1.74%
    Ms Pauline Therese Gately 9,930,583 1.57%
    Interdale Pty Ltd (Maple Super A/C) 7,035,496 1.11%
    Mr Kieran John O'Brien 6,021,500 0.95%
    Mr Ashley Hardwick 5,402,778 0.85%
    Jasforce Pty Ltd 5,049,873 0.80%
    Mr Ronald Michael Dufficy 4,814,835 0.76%
    Bnp Paribas Nominees Pty Ltd Acf Clearstream 4,539,590 0.72%
    Cotton On Innovation Fund Pty Ltd 4,472,461 0.71%
    D & G Health Llc 4,119,229 0.65%
    Kaneden Enterprises Pty Ltd (Roseburgh Family Super A/C) 4,000,000 0.63%
    Mr Nicky Alfred Kleyn 4,000,000 0.63%
    Cotton On Innovation Fund Pty Ltd i 3,928,750 0.62%

    Profile

    since

    Note